EU Blocks Illumina’s Deal to Buy Grail on Antitrust Grounds By Investing.com
© Reuters. By Geoffrey Smith Investing.com — The European Union has blocked Illumina’s (NASDAQ:) $7.1 billion acquisition of cancer detection test maker Grail, saying that Illumina failed to address its concerns about the deal restricting competition. […]
